Plain-English translation of NCT07422337 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study is looking at whether children who were treated for B-cell acute lymphoblastic leukemia (a type of blood cancer) with a medication called blinatumomab still have protection from the vaccines they received in early childhood. Chemotherapy and cancer treatments can sometimes weaken or erase the protection that vaccines provide. This research will help doctors figure out which children need booster shots and when they should receive them.
Intensive cancer treatment can destroy the immune cells that remember your vaccinations, leaving you unprotected against diseases you were previously vaccinated against. Right now, doctors don't have clear guidelines for which children treated with this medication need revaccination, so this study aims to fill that gap.
You likely qualify if…
You likely don't qualify if…
Researchers will compare two groups of children: those who received the cancer medication and those who did not. You would likely have blood work done to measure your antibody levels (which show how well your vaccines are still protecting you), and researchers would review your medical records to track your vaccination history and treatment. The study is recruiting participants now, and specific visit schedules would be determined by the research team.
AI-generated summary from trial data · Jul 3, 2026 · Not medical advice
United States